학술논문
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
Document Type
Article
Author
Elsawy, M.; Chavez, J.C.; Avivi, I.; Larouche, J.-F.; Wannesson, L.; Cwynarski, K.; Osman, K.; Davison, K.; Rudzki, J.D.; Dahiya, S.; Dorritie, K.; Jaglowski, S.; Radford, J.; Morschhauser, F.; Cunningham, D.; Martin Garcia-Sancho, A.; Tzachanis, D.; Ulrickson, M.L.; Karmali, R.; Kekre, N.; Thieblemont, C.; Enblad, G.; Dreger, P.; Malladi, R.; Joshi, N.; Wang, W.-J.; Solem, C.T.; Snider, J.T.; Cheng, P.; To, C.; Kersten, M.J.
Source
In: Blood . (Blood, 24 November 2022, 140(21):2248-2260)
Subject
Language
English
ISSN
15280020
00064971
00064971